Continuous glucose monitoring (CGM) is a small wearable device that tracks your glucose throughout the day and night, notifying you of highs and lows so you can take action.1
CGM helps to minimize the guesswork that comes from making decisions based solely on a number from a blood glucose meter reading, for better diabetes management.*
Whether you have type 1 or type 2 diabetes, CGM can help you make more informed treatment decisions and can lead to better glycemic control.
So how does this technology work? A CGM system consists of three parts: a glucose sensor, a transmitter and a small receiver that displays real-time glucose information.
A discrete sensor located just underneath the skin measures your glucose levels.
This piece fits onto the sensor and sends data wirelessly to your display device.
Glucose activity is shown in vivid colors so you can easily see when it’s trending high, low or within range.
Dexcom CLARITY® is a unique cloud-based reporting system that allows you and your healthcare professional to access and track your glucose data anywhere2 and quickly identify critical glucose patterns.
If you are ready to take the next step, the process is simple. Provide us with a few details and we will contact you to begin your order.
* A minimum of 2 fingersticks a day is required for calibration.The Dexcom G5 Mobile Continuous Glucose Monitoring System may require more.
1 BRIEF SAFETY STATEMENT
The Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System ("G5") is a glucose monitoring system indicated for the management of diabetes in persons age 2 years and older. The G5 is designed to replace fingerstick blood glucose testing for diabetes treatment decisions. The G5 also aids in the detection of episodes of hyperglycemia and hypoglycemia. The G5 is intended for single patient use and requires a prescription. CONTRAINDICATIONS Do not rely on the G5 CGM data if you have recently taken acetaminophen. Remove the G5 (sensor, transmitter, and receiver) before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment. The G5 is MR Unsafe. Do not bring any portion of the G5 into the MRI environment. WARNING CGM-based diabetes treatment decisions are only approved with the G5, not previous generations of Dexcom CGM systems. Calibrate at least once every 12 hours using a fingerstick. If your G5 does not display a sensor glucose reading and an arrow, or if you are getting inaccurate or inconsistent readings, take a fingerstick. If your glucose readings and alerts do not match your symptoms or expectations, take a fingerstick to confirm. Failure to do so may lead to hyperglycemia or hypoglycemia. The G5 is not approved for use in pregnant women, persons on dialysis or critically ill persons. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation on or near the sensor insertion point. Report broken sensors to Dexcom Technical Support. Sensor placement is not approved for sites other than under the skin of the belly (ages 2 years and older) or upper buttocks (ages 2-17 years). To “share” data, you need an internet connection and a separate compatible smart device running the Dexcom Follow App. Contact Dexcom Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information.
2 Internet service (Wi-Fi or cellular) required.